Product Information
ENOXAPARIN 300 MG/3 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $10.2663 per ML under NDC 63323053903. Its NADAC has been published 264 times since May 6, 2020.
FDA first approved this application on Mar 29, 1993. Its Orange Book therapeutic-equivalence code is AP.
Strength
300 mg/3mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323053903
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA020164FDA Approved
3/29/1993
TE Code
AP
On Market Since
6/18/2019
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 300 MG/3 ML VIAL has been published 264 times since May 6, 2020, and over the history we have for it it has declined 34.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.2663 per ML |
|---|---|
| All-time high | $15.7340 (Jan 13, 2021) |
| All-time low | $9.8758 (Jun 17, 2026) |
| 52-week high | $11.6405 |
| 52-week low | $9.8758 |
| Median price | $12.5053 |
| Average price | $12.4695 |
| Largest weekly change | -20.5% (Jan 20, 2021) |
| Weeks tracked | 264 |
| Tracking since | May 6, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENOXAPARIN 300 MG/3 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 300 MG/3 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $10.2663 per ML (NDC 63323053903), effective Aug 19, 2026.
How has the price of ENOXAPARIN 300 MG/3 ML VIAL changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has declined 34.8%. It has been tracked across 264 weekly CMS publications since May 6, 2020.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 300 MG/3 ML VIAL?
Since May 6, 2020, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has ranged from a low of $9.8758 (Jun 17, 2026) to a high of $15.7340 (Jan 13, 2021), with a median of $12.5053 per ML.
Are there cheaper alternatives to ENOXAPARIN 300 MG/3 ML VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENOXAPARIN 300 MG/3 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures ENOXAPARIN 300 MG/3 ML VIAL?
ENOXAPARIN 300 MG/3 ML VIAL (NDC 63323053903) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.